Elsevier

Peptides

Volume 18, Issue 9, 1997, Pages 1349-1355
Peptides

Article
Stimulation of Tachykinin NK-3 Receptors in the Nucleus Basalis Magnocellularis Reduces Alcohol Intake in Rats

https://doi.org/10.1016/S0196-9781(97)00189-7Get rights and content

Abstract

Ciccocioppo, R., I. Panocka, C. Polidori, G. De Caro, D. Regoli and M. Massi.

Stimulation of tachykinin NK-3 receptors in the nucleus basalis magnocellularis reduces alcohol intake in rats.

Peptides 18(9) 1349–1355, 1997.—Injections in the nucleus basalis magnocellularis (NBM) of the tachykinin (TK) NK-3 receptor agonist [Asp5,6,MePhe8]substance P(5–11), also referred to as amino-senktide (NH2-SENK), markedly reduced alcohol intake in genetically selected alcohol-preferring rats, offered 10% ethanol 2 h/day. The threshold dose in the NBM was 0.5 ng/site, while neither 1 nor 10 ng/rat of NH2-SENK inhibited alcohol intake following administration into the lateral ventricle. Injection of NH2-SENK, 25 ng/site, in the NBM did not modify water or food intake in water deprived rats, providing evidence for the behavioral selectivity of the effect on ethanol intake. The selective TK NK-3 receptor antagonist, R-820, injected in the NBM at the dose of 1000 ng/site 5 min before NH2-SENK 5 ng/site, significantly reduced the effect of NH2-SENK. The selective TK NK-1 receptor agonist [Sar9,Met(O2)11]substance P inhibited alcohol intake following injection in the NBM only at 25 ng/site; but the same dose induced marked grooming and inhibited also water intake in water deprived rats. The present results confirm that TK NK-3, but not NK-1, receptor agonists selectively inhibit ethanol intake in alcohol-preferring rats and suggest that the NBM is a site of action for their effect.

Section snippets

Animals

Male genetically selected alcohol-preferring rats were employed. They were bred in the Department of Pharmacological Sciences and Experimental Medicine of the University of Camerino for 22 generations, starting from Sardinian alcohol-preferring rats of the 13th generation, provided by the Department of Neurosciences of the University of Cagliari 14, 15.

Two months old alcohol-preferring rats were selected for their preference for 10% ethanol solution (v/v). They were offered free choice between

Experiment 1

Effect on ethanol intake of the selective NK-3 receptor agonist NH2-SENK, injected either into the LV or into the NBM.

Method

Two groups of alcohol-preferring rats were used. The first (n = 8) was injected into the LV with NH2-SENK at doses of 1–125 ng/rat, while the second group (n = 6) received NH2-SENK into the NBM, at doses of 0.25–25 ng/site. In both groups drug administration took place 1 min before access to ethanol. Both groups were tested also with central injection of isotonic saline (controls). Ethanol and water intake were recorded 15, 30, 60 and 120 min later.

The experiment was carried out according to a

Results

As shown on Fig. 2A, NH2-SENK inhibited ethanol intake following ICV injection. The analysis of variance revealed a statistically significant treatment effect [F(5, 35) = 5.69; p < 0.001], time effect [F(3, 21) = 43.40; p < 0.001], but a non-significant treatment-time interaction [F(15, 105) = 1.75; p > 0.05]. The effect was statistically significant at 31, 125 and 500 ng/rat, but not at 1 or 10 ng/rat.

NH2-SENK evoked a more potent inhibition of ethanol intake following bilateral injection

Experiment 2

Effect of NH2-SENK, injected into the NBM, on water and food intake of water deprived rats

Method

To assess the behavioral selectivity of its effect, NH2-SENK was tested on water and food intake of rats, that had been water deprived for 20 h. One min before access to water, rats (n = 6) were injected into the NBM either with isotonic saline (controls) or NH2-SENK, 5 ng/site. Water and food intake were measured 15, 30, 60, 120 and 240 min after injection. Each animal received isotonic saline (controls) and NH2-SENK at interval of 7 days.

Results

As shown on Fig. 3, bilateral injection of NH2-SENK, 5 ng/site, left essentially unmodified water and food intake, following 20 h water deprivation.

The analysis of variance of the water intake data revealed non-significant treatment effect [F(1, 5) = 1.08; p > 0.05] and treatment-time interaction [F(4, 20) = 2.84; p > 0.05], but a significant time effect [F(4, 20) = 210.61; p < 0.001]

The analysis of variance of the food intake data revealed non-significant treatment effect [F(1, 5) = 0.45; p >

Experiment 3

Effect of the selective NK-3 receptor antagonist R820 on the effect of NH2-SENK on alcohol intake

Method

One group of 5 rats was tested with the NK-3 receptor antagonist R820, 1000 ng/site, or its vehicle, which were bilaterally injected in a volume of 0.3 μl 5 min before treatment with vehicle (controls) or with NH2-SENK, 5 ng/site.

The experiment was carried out according to a within subject design, in which animals received the 4 pharmacological treatments at intervals of 3–4 days.

Results

The dose of 1000 ng/site was chosen because in a preliminary experiment it did not modify per se alcohol intake, while providing a favorable antagonist:agonist ratio (200:1).

The overall analysis of variance revealed a statistically significant treatment effect [F(3, 12) = 4.14; p < 0.05]. As shown in Fig. 4A, NH2-SENK, 5 ng/site, evoked a significant reduction of ethanol intake in comparison to controls [F(1, 4) = 34.46; p < 0.01]; R820, 1000 ng/site, did not significantly modify ethanol

Experiment 4

Effect on ethanol intake of the selective NK-1 receptor agonist [Sar9,Met(O211]SP, injected into the NBM

Method

[Sar9,Met(O211]SP, 0.5–75 ng/site, or its vehicle were bilaterally injected into the NBM of 7 rats in a volume of 0.3 μl/site, 1 min before access to ethanol. Ethanol and water intake were recorded 15, 30, 60 and 120 min later.

The experiment was carried out according to a within subject design, in which animals received the 5 pharmacological treatments at intervals of 3–4 days.

Results

The effect on ethanol intake of [Sar9,Met(O2)11]SP following injection into the NBM is reported in Fig. 5. The overall analysis of variance revealed a significant treatment effect [F(4, 24) = 3.07; p < 0.05], time effect [F(3, 18) = 76.26; p < 0.001], but a non-significant treatment-time interaction. The effect was statistically significant only at 25 and 75 ng/site. Following administration of these doses marked grooming was observed in treated rats, thus raising the question of the

Experiment 5

Effect of the selective NK-1 receptor agonist [Sar9,Met(O2)11]SP, injected into the NBM, on water and food intake of water deprived rats

Method

To assess the behavioral selectivity of the effect of [Sar9,Met(O2)11]SP in the NBM, its effect was evaluated on water and food intake of 7 rats, that had been water deprived for 20 h. One min before access to water, rats were injected into the NBM with isotonic saline (controls) or [Sar9,Met(O2)11]SP, 25 ng/site. Each animal received isotonic saline (controls) and [Sar9,Met(O2)11]SP at interval of 7 days.

Results

As shown in Fig. 6, bilateral injection of [Sar9,Met(O2)11]SP, 25 ng/site, significantly reduced water intake, induced by 20 h water deprivation. The analysis of variance revealed a significant treatment effect [F(1, 6) = 10.06; p < 0.05], time effect [F(3, 18) = 237.7; p < 0.01], but a non-significant treatment-time interaction.

The analysis of variance of the food intake data revealed non-significant treatment effect [F(1, 6) = 2.87; p > 0.05] and treatment-time interaction, but a significant

Discussion

Previous studies of our group have shown that the ICV administration of selective NK-3, but not of NK-1 or NK-2, receptor agonists selectively reduces alcohol intake in genetically selected alcohol-preferring rats [5]. Reduction of alcohol intake was also observed following subcutaneous injection [6]of the selective NK-3 receptor agonist senktide [38], that readily crosses the blood-brain barrier [32]. In previous studies the effect was evaluated in fluid deprived rats 5, 6, 27because, when

Acknowledgements

This work was supported by grants from University of Camerino and Ministero Pubblica Istruzione Rome, Italy (Fondi 40 and 60%).

References (38)

  • A.K. Johnson et al.

    The cerebral ventricles as the avenue for the dipsogenic action of intracerebral angiotensin

    Brain Res.

    (1975)
  • R. Laufer et al.

    Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand

    J. Biol. Chem.

    (1986)
  • M. Perfumi et al.

    The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats

    Pharmacol. Biochem. Behav.

    (1991)
  • D. Regoli et al.

    New selective agonists for neurokinin receptorspharmacological tools for receptor characterization

    Trends Pharmacol. Sci.

    (1988)
  • D. Regoli et al.

    Neurokinin receptor subtypesCharacterization by biological assays

    Life Sci.

    (1994)
  • R.M. Teixeira et al.

    Effects of central administration of tachykinin receptor agonists and antagonists on plus maze behavior in mice

    Eur. J. Pharmacol.

    (1996)
  • R.T. Bartus et al.

    The cholinergic hypothesis of geriatric memory disfunction

    Science

    (1992)
  • J.P. Bolam et al.

    Substance P-containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrainA double immunocytochemical study in the rat

    Brain Res.

    (1986)
  • R. Ciccocioppo et al.

    Selective agonists at NK3 tachykinin receptors inhibit alcohol intake in Sardinian alcohol-preferring rats

    Brain Res. Bull.

    (1994)
  • Cited by (20)

    • Neurokinin receptors in drug and alcohol addiction

      2020, Brain Research
      Citation Excerpt :

      ICV infusion of NK3R agonists acutely suppress alcohol consumption in alcohol preferring rats but do not affect food/water intake, alcohol metabolism, or alcohol-induced conditioned taste aversion (Ciccocioppo, 1998; Perfumi, 1991; Ciccocioppo, 1994; Polidori, 1997), and this effect is mimicked by systemic injection (Ciccocioppo, 1995). This effect of NK3R action has been suggested to be localized to the nucleus basalis magnocellularis, a cholinergic nucleus of the basal forebrain (Ciccocioppo, 1997), and the lateral hypothalamus, a major subregion of the hypothalamus that is involved in motivated behavior (Panocka, 1998). Intriguingly, these two regions have also been found to play a role in SP effects on DA function and reward behavior (see above) (Holzhauer-Oitzl et al., 1987; Boix, 1995).

    • Sensitization of hypervigilance effects of cocaine can be induced by NK3 receptor activation in marmoset monkeys

      2013, Drug and Alcohol Dependence
      Citation Excerpt :

      SP, NKA and NKB have a high binding affinity to NK1-Rs, NK2-Rs, and NK3-Rs, respectively, but all the neurokinins bind to all three NK-Rs (Massi et al., 2000; Hökfelt et al., 2001). The NK3-R was particularly linked to alcohol- (Ciccocioppo et al., 1994, 1995, 1997, 1998) and cocaine-addiction (De Souza Silva et al., 2008; Foroud et al., 2008). In rats, NK3-R agonism potentiated the cocaine-induced dopamine (DA) increase in the nucleus accumbens core, but not shell, while antagonism potentiated cocaine's effects in both shell and core subregions.

    • Is there still a future for neurokinin 3 receptor antagonists as potential drugs for the treatment of psychiatric diseases?

      2012, Pharmacology and Therapeutics
      Citation Excerpt :

      There are several lines of evidence suggesting that the NK3 receptor may be involved in reward processes (for a review, see Massi et al., 2000). Massi and colleagues showed that central or peripheral infusions of the NK3 receptor agonists aminosenktide and senktide exerted rewarding effects in rats in the place conditioning paradigm (Ciccocioppo et al., 1998), but inhibited ethanol intake in the genetically selected Sardinian alcohol-preferring rats (Ciccocioppo et al., 1994, 1995, 1997; Panocka et al., 1998; Perfumi et al., 1991). These latter effects were abolished by the peptide NK3 receptor antagonist R820 when both the agonist and the antagonist were administered in the nucleus basalis magnocellularis (Ciccocioppo et al., 1997).

    • Effect of social isolation on ethanol consumption and substance P/neurokinin expression in Wistar rats

      2005, Alcohol
      Citation Excerpt :

      In a series of studies with the Sardinian alcohol–preferring rats, NK-3 receptor agonists inhibited 10% ethanol intake following intracerebral ventricular administration (Ciccocioppo et al., 1994; Perfumi et al., 1991; Polidori et al., 1997). This effect can be reversed by administration of a NK-3 receptor antagonist (Ciccocioppo et al., 1997). The central administration of NK-3 receptor agonists has also been demonstrated to produce conditioned place preference (Ciccocioppo et al., 1998), suggesting that ethanol intake reduction by NK-3 agonists may be due to alteration of the rewarding properties of ethanol (Massi et al., 2000).

    View all citing articles on Scopus
    View full text